Reconstitution of bactericidal activity in chronic granulomatous disease cells by glucose-oxidase-containing liposomes. 2001

C E Gerber, and G Bruchelt, and U B Falk, and A Kimpfler, and O Hauschild, and S Kuçi, and T Bächi, and D Niethammer, and R Schubert
University Children's Hospital, Department of Hematology and Oncology, Tübingen, Germany. claudia.gerber@med-tuebingen.de

Chronic granulomatous disease (CGD) is an inherited primary immunodeficiency characterized by phagocytes devoid of a functioning nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. The failure of CGD phagocytes to produce reactive oxygen species (ROS) results in a marked increase in the susceptibility of affected patients to life-threatening bacterial and fungal infections. This study investigated whether loading of CGD phagocytes with glucose oxidase (GO)-containing liposomes (GOLs) could restore cellular production of bactericidal ROS (eg, H2O2 and HOCl) in vitro. Results indicate that GO encapsulated in liposomes enabled NADPH oxidase-deficient phagocytes to use H2O2 for the production of highly bactericidal HOCl. The intracellular colocalization of bacteria and liposomes (or liposome-derived ferritin) was demonstrated by confocal laser microscopy and electron microscopy. After uptake of GOLs (approximately 0.2 U/mL at 1 mM total lipid concentration, size approximately 180 nm), CGD granulocytes produced HOCl levels comparable to those of normal phagocytes. Remarkably, after treatment with GOLs, CGD phagocytes killed Staphylococcus aureus as efficiently as normal granulocytes. Moreover, treated cells retained sufficient motility toward chemotactic stimuli as measured by chemotaxis assay. Side effects were evaluated by measuring the H2O2 concentrations and the production of methemoglobin in whole blood. These studies revealed that H2O2 produced by GOLs was degraded immediately by the antioxidative capacity of whole blood. Elevated methemoglobin levels were observed only after application of extremely high amounts of GOLs (2 U/mL). In summary, the application of negatively charged GOLs might provide a novel effective approach in the treatment of patients with CGD at high risk for life-threatening infections.

UI MeSH Term Description Entries
D006997 Hypochlorous Acid An oxyacid of chlorine (HClO) containing monovalent chlorine that acts as an oxidizing or reducing agent. Hypochlorite,Hypochlorous Acids
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008706 Methemoglobin Ferrihemoglobin
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002633 Chemotaxis The movement of cells or organisms toward or away from a substance in response to its concentration gradient. Haptotaxis
D004339 Drug Compounding The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814). Drug Formulation,Drug Preparation,Drug Microencapsulation,Pharmaceutical Formulation,Compounding, Drug,Formulation, Drug,Formulation, Pharmaceutical,Microencapsulation, Drug,Preparation, Drug

Related Publications

C E Gerber, and G Bruchelt, and U B Falk, and A Kimpfler, and O Hauschild, and S Kuçi, and T Bächi, and D Niethammer, and R Schubert
June 1996, Experimental cell research,
C E Gerber, and G Bruchelt, and U B Falk, and A Kimpfler, and O Hauschild, and S Kuçi, and T Bächi, and D Niethammer, and R Schubert
March 1970, Blood,
C E Gerber, and G Bruchelt, and U B Falk, and A Kimpfler, and O Hauschild, and S Kuçi, and T Bächi, and D Niethammer, and R Schubert
June 2012, Experimental biology and medicine (Maywood, N.J.),
C E Gerber, and G Bruchelt, and U B Falk, and A Kimpfler, and O Hauschild, and S Kuçi, and T Bächi, and D Niethammer, and R Schubert
February 1967, Science (New York, N.Y.),
C E Gerber, and G Bruchelt, and U B Falk, and A Kimpfler, and O Hauschild, and S Kuçi, and T Bächi, and D Niethammer, and R Schubert
February 1977, The Journal of pediatrics,
C E Gerber, and G Bruchelt, and U B Falk, and A Kimpfler, and O Hauschild, and S Kuçi, and T Bächi, and D Niethammer, and R Schubert
November 1994, Blood,
C E Gerber, and G Bruchelt, and U B Falk, and A Kimpfler, and O Hauschild, and S Kuçi, and T Bächi, and D Niethammer, and R Schubert
June 1979, Pediatric research,
C E Gerber, and G Bruchelt, and U B Falk, and A Kimpfler, and O Hauschild, and S Kuçi, and T Bächi, and D Niethammer, and R Schubert
January 2006, Biotechnology progress,
C E Gerber, and G Bruchelt, and U B Falk, and A Kimpfler, and O Hauschild, and S Kuçi, and T Bächi, and D Niethammer, and R Schubert
August 1969, Diseases of the chest,
C E Gerber, and G Bruchelt, and U B Falk, and A Kimpfler, and O Hauschild, and S Kuçi, and T Bächi, and D Niethammer, and R Schubert
January 1977, Annales d'immunologie,
Copied contents to your clipboard!